Clinical Trial

A Study to Investigate the Effect of a Low-fat Meal and Evening Dosing on KAI-7535 in Participants Living With Obesity or Overweight

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to evaluate the effect of a meal and evening dosing on the pharmacokinetics (PK) of KAI 7535 in healthy participants living with obesity or overweight.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-12-08; most recent amendment 2026-01-28.
Status change: Active, Not Recruiting → Completed 2026-01-28
Status change: Recruiting → Active, Not Recruiting 2026-01-22
Status change: Not Yet Recruiting → Recruiting 2026-01-07
Trial Details
NCT Number NCT07294898
Lead Sponsor Kailera
Conditions Obesity, Overweight
Enrollment 18 participants
Start Date 2025-12-15
Primary Completion 2026-01-26 (estimated)
Study Completion 2026-01-26 (estimated)
Updated on ClinicalTrials.gov 2026-01-29